Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review-Reference-Cited by-同舟云学术

Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review

Published:2020-09 Issue:5 Volume:16 Page:324-332
ISSN:2173-5743
Container-title:Reumatología Clínica (English Edition)
language:en
Short-container-title:Reumatología Clínica (English Edition)

Author:

Calvo Alén Jaime,Pérez Trinidad,Romero Yuste Susana,Ferraz-Amaro Iván,Alegre Sancho Juan José,Pinto Tasende José Antonio,Maceiras Pan Francisco,Quevedo Juan Carlos,Hernández-Hernández M. Vanesa,Hidalgo Calleja Cristina,San Martín Álvarez Alejandro,Tevar Sánchez María Isabel,Sanmartí Raimon

Funder

Roche

Publisher

Elsevier BV

Reference34 articles.

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update;Smolen;Ann Rheum Dis,2017

2. Treating rheumatoid arthritis to target: recommendations of an international task force;Smolen;Ann Rheum Dis,2010

3. Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice;Versteeg;Clin Rheumatol,2018

4. Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study;De Andrade;Rheumatol Int,2017

5. Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis;Daien;RMD Open,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly ε-Caprolactone Nanoparticles for Sustained Intra-Articular Immune Modulation in Adjuvant-Induced Arthritis Rodent Model;Pharmaceutics;2022-02-26